{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:39:04Z","timestamp":1788871144817,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia","doi-asserted-by":"crossref","award":["NN-1-038\/10"],"award-info":[{"award-number":["NN-1-038\/10"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.pharep.2014.10.004","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T02:36:02Z","timestamp":1414031762000},"page":"305-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The effect of ezetimibe-statin combination on steroid hormone production in men with coronary artery disease and low cholesterol levels"],"prefix":"10.1007","volume":"67","author":[{"given":"Robert","family":"Krysiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Kowalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witold","family":"\u017bmuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogus\u0142aw","family":"Okopie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2014.10.004_bib0005","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0828-282X(06)70301-4","article-title":"Lower is better: implications of the treating to new targets (TNT) study for Canadian patients","volume":"22","author":"Fitchett","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pharep.2014.10.004_bib0010","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.pharep.2014.10.004_bib0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.hpc.0000086202.17560.4b","article-title":"PROVE-IT TIMI 22 study: potential effects on critical pathways for acute coronary syndrome","volume":"2","author":"Cannon","year":"2003","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.pharep.2014.10.004_bib0020","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pharep.2014.10.004_bib0025","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS): ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"32","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharep.2014.10.004_bib0030","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4158\/EP13176.CS","article-title":"American Association of Clinical Endocrinologists\u2019comprehensive diabetes management algorithm 2013 consensus statement-executive summary","volume":"19","author":"Garber","year":"2013","journal-title":"Endocr Pract"},{"issue":"25 Pt B","key":"10.1016\/j.pharep.2014.10.004_bib0035","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharep.2014.10.004_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000134751","article-title":"Steroidogenic enzymes","volume":"13","author":"Miller","year":"2008","journal-title":"Endocr Dev"},{"key":"10.1016\/j.pharep.2014.10.004_bib0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/10408360500295113","article-title":"Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism","volume":"42","author":"Hooper","year":"2005","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.pharep.2014.10.004_bib0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0009-9120(97)00040-4","article-title":"Effect of decreased plasma low-density lipoprotein levels on adrenal and testicular function in man","volume":"30","author":"Arem","year":"1997","journal-title":"Clin Biochem"},{"issue":"Suppl. 4","key":"10.1016\/j.pharep.2014.10.004_bib0055","first-page":"95","article-title":"Chronic adrenal failure and hypergonadotropic hypogonadism in a patient with abetalipoproteinemia","volume":"16","author":"Krysiak","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.pharep.2014.10.004_bib0060","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/bcpt.12169","article-title":"The effect of aggressive rosuvastatin treatment on steroid hormone production in men with coronary artery disease","volume":"114","author":"Krysiak","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.pharep.2014.10.004_bib0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1741-7015-11-57","article-title":"The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Schooling","year":"2013","journal-title":"BMC Med"},{"issue":"96","key":"10.1016\/j.pharep.2014.10.004_bib0070","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1210\/jc.2011-1137","article-title":"Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis","volume":"11","author":"Araujo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2014.10.004_bib0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MED.0b013e3283383031","article-title":"Androgens and cardiovascular disease","volume":"17","author":"Yeap","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.pharep.2014.10.004_bib0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2009.10.037","article-title":"Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors","volume":"210","author":"Akishita","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2014.10.004_bib0085","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pharep.2014.10.004_bib0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1741-7015-11-108","article-title":"Testosterone and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials","volume":"11","author":"Xu","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.pharep.2014.10.004_bib0095","series-title":"Health Canada Summary safety review \u2013 testosterone replacement products \u2013 cardiovascular risk","year":"2014"},{"key":"10.1016\/j.pharep.2014.10.004_bib0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1517\/17425255.3.3.441","article-title":"Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials","volume":"3","author":"Sweeney","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharep.2014.10.004_bib0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14779072.6.4.447","article-title":"Ezetimibe: cholesterol lowering and beyond","volume":"6","author":"Bays","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.pharep.2014.10.004_bib0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.reprotox.2013.12.010","article-title":"Statin drugs markedly inhibit testosterone production by rat Leydig cells in vitro: implications for men","volume":"45C","author":"Klinefelter","year":"2014","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.pharep.2014.10.004_bib0115","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1095\/biolreprod.109.078667","article-title":"Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat","volume":"81","author":"Rzepczynska","year":"2009","journal-title":"Biol Reprod"},{"key":"10.1016\/j.pharep.2014.10.004_bib0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/FJC.0b013e318211703b","article-title":"The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia","volume":"57","author":"Krysiak","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharep.2014.10.004_bib0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2796.2011.02394.x","article-title":"The effect of ezetimibe, administered alone or in combination with simvastatin, on lymphocyte cytokine release in patients with elevated cholesterol levels","volume":"271","author":"Krysiak","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharep.2014.10.004_bib0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1472-8206.2011.00932.x","article-title":"The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia","volume":"26","author":"Krysiak","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pharep.2014.10.004_bib0135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0960-0760(91)90333-Z","article-title":"The HMG-CoA reductase inhibitor simvastatin suppresses human testicular testosterone synthesis in vitro by a selective inhibitory effect on 17-ketosteroid-oxidoreductase enzyme activity","volume":"38","author":"Smals","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pharep.2014.10.004_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.111.094714","article-title":"Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells","volume":"86","author":"Ortega","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.pharep.2014.10.004_bib0145","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0195-668X(02)00807-2","article-title":"Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia","volume":"24","author":"Knopp","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharep.2014.10.004_bib0150","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/BF03345757","article-title":"A multi-center, open label, crossover designed prospective study evaluating the effects of lipid lowering treatment on steroid synthesis in patients with Type 2 diabetes (MODEST Study)","volume":"32","author":"Kanat","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.pharep.2014.10.004_bib0155","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1345\/aph.1R127","article-title":"Dyslipidemia: management using optimal lipid-lowering therapy","volume":"46","author":"Ito","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pharep.2014.10.004_bib0160","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol Cell Endocrinol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014003168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014003168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:46Z","timestamp":1752611746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2014.10.004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1734114014003168"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2014.10.004","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of ezetimibe-statin combination on steroid hormone production in men with coronary artery disease and low cholesterol levels","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2014.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}